Found 733 events where Vaccine is VARZOS and Serious

VAERS ID: 296058 (history)   Vaccinated: 2007-10-29 Age: 81.0   Onset: 2007-10-29, Days after vaccination: 0 Gender: Female   Submitted: 2007-11-07, Days after onset: 9 Location: New Jersey   Entered: 2007-11-08, Days after submission: 1	Life Threatening? No Died? No Permanent Disability? Yes Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: FOSAMAX; LIPITOR; VASOTEC; DIOVAN; COUMADIN Current Illness: Preexisting Conditions: Unknown Diagnostic Lab Data: Unknown CDC 'Split Type': WAES0711USA00145
Vaccination Manufacturer Lot Dose Route Site PPV: PNEUMO (PNEUMOVAX) MERCK & CO. INC.     UN LA VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC. 0740U   UN RA
Administered by: Other     Purchased by: Other Symptoms: Erythema, Oedema peripheral, Pain in extremity SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (broad) Write-up: Information has been received from a certified medical assistant concerning an 81 year old female who on 29-OCT-2007 was vaccinated with a dose of Zostavax (Oka/Merck) (lot# 657767/0740U) in the right deltoid. Concomitant vaccination administered on that day included a dose of Pneumovax 23 (MSD) in the left arm. Other concomitant drug therapy included alendronate sodium (MSD), valsartan (DIOVAN), warfarin sodium (COUMADIN), enalapril maleate (VASOTEC) and atorvastatin calcium (LIPITOR). On that same day, the patient experienced pain, redness and swelling in her right arm. The patient was seen by the physician. The patient was noted to be recovering. There was no product quality complaint. Pain, redness and swelling were considered to be disabling by the reporter. Additional information has been requested.
VAERS ID: 296238 (history)   Vaccinated: 2007-08-30 Age: 75.0   Onset: 0000-00-00 Gender: Male   Submitted: 2007-11-05 Location: Nevada   Entered: 2007-11-09, Days after submission: 4	Life Threatening? No Died? No Permanent Disability? No Recovered? Yes ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: Current Illness: No illness Preexisting Conditions: None PMH: HTN, allergic rhinitis, hearing loss, cataracts, HTN, pneumonia, osteoarthritis, diverticulosis, colonic polyps, right BBB, peyronie''s disease, impaired fasting glucose, mitral regurgitation, ex-smoker, hyperlipidemia, renal insufficiency, BPH. Diagnostic Lab Data: LABS: EMG as outpatient revealed sensory neuropathy. Anemic & transfused. Stools (+) for occult blood. CT abdomen & pelvis revealed renal cyst. Admit CBC WBC 13.4 (H), neutros 73.7% (H), lymphs 13.2% (L), H/H 8.7/25.2. Alk phosphatase 1 CDC 'Split Type':
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC. 0882U 0 SC LA
Administered by: Private     Purchased by: Unknown Symptoms: Anaemia, Asthenia, Autoimmune disorder, Blood alkaline phosphatase increased, Computerised tomogram abnormal, Decreased appetite, Diffuse axonal injury, Electromyogram abnormal, Haematocrit decreased, Haemoglobin decreased, Hyporeflexia, Lymphocyte count decreased, Nerve conduction studies abnormal, Neuropathy peripheral, Neutrophil percentage increased, Occult blood positive, Pain in extremity, Paraesthesia, Peripheral sensory neuropathy, Plasmapheresis, Renal cyst, Tarsal tunnel syndrome, Transfusion, Weight decreased, White blood cell count increased SMQs:, Rhabdomyolysis/myopathy (broad), Liver related investigations, signs and symptoms (broad), Haematopoietic erythropenia (broad), Haematopoietic leukopenia (narrow), Peripheral neuropathy (narrow), Haemorrhage laboratory terms (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Gastrointestinal haemorrhage (narrow), Biliary system related investigations, signs and symptoms (broad), Guillain-Barre syndrome (broad), Accidents and injuries (narrow) Write-up: 4-5 days following the vaccine I began to feel weak had no interest in eating. I could not look at food. I lost 15 lbs in a weeks time. Neurologist placed me in hospital. I had my blood cleansed through plasma treatment for 5 days. 11/16/07 Reviewed hospital medical records which reveal patient experienced weakness, loss of appetite & pain/paresthesia of LEs. Neuro consult done as outpatient. Reflexes were 1/4 & symmetric. Admitted 10/16-10/22/2007. Tx w/plasmapheresis x 5 & improved. FINAL DX: acute peripheral neuropathy, likely autoimmune s/p vax; anemia, likely due to NSAID use; heme (+) stools. 11/27/07 Reviewed pcp medical records of 8/30/07 visit which included vaccination lot# & reveal patient was in usual state of good general health on day of vax. VAERS database updated w/vax info. 12/14/07 Received outpatient EMG done 10/5/07 which states patient had bilateral leg burning pain s/p zoster vax x 1 month. EMG/NCS abnormal & c/w mild sensory neuropathy & bilateral anterior tarsal tunnel syndrome w/related chronic axonal injury.
VAERS ID: 296419 (history)   Vaccinated: 2007-10-10 Age: 60.0   Onset: 2007-10-26, Days after vaccination: 16 Gender: Female   Submitted: 2007-11-09, Days after onset: 14 Location: North Carolina   Entered: 2007-11-12, Days after submission: 3	Life Threatening? Yes Died? No Permanent Disability? Yes Recovered? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: None Current Illness: Stomach virus; Allergic reaction to antibiotics; Drug hypersensitivity Preexisting Conditions: Diagnostic Lab Data: Unknown 11/19/07-records received-Nerve conduction testing revealed moderately severe predominately motor demylinating polyneuropathy. MRI brain showing moderately prominent areas of white matter hyperintensity with intrepretation favoring CDC 'Split Type': WAES0711USA01443
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     UN UN
Administered by: Other     Purchased by: Other Symptoms: Demyelinating polyneuropathy, Guillain-Barre syndrome, Headache, Lumbar puncture, Muscular weakness, Nerve conduction studies abnormal, Nuclear magnetic resonance imaging brain abnormal, Pyrexia SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow) Write-up: Information has been received from a physician concerning a 60 year old female with stomach virus, allergy to Levaquin and drug hypersensitivity to codeine who on 10-OCT-2007 was vaccinated with a dose of Zostavax (Oka/Merck) (invalid lot# 0761409). There was no concomitant medication. In October 2007, the physician reported that "after receiving Zostavax (Oka/Merck) the patient had severe motor weakness of all extremities, but with no sensory loss, onset reported as 26-Oct-2007. The patient then saw a neurologist then admitted the patient immediately to the hospital. At the hospital the patient was diagnosed with Guillain-Barre Syndrome and was hospitalized for 6 days. Unspecified medical attention was sought. No product quality complaint. The physician reported that the patient is recovering and is going through physical therapy" Guillain-Barre Syndrome was considered serious due to hospitalization, immediately life-threatening and disabling. Upon internal review, Guillain-Barre Syndrome was also considered an Other Important Medical Event. Additional information has been requested. 11/19/07-records received for DOS 10/30-11/4/07-DC DX: Guillain-Barre syndrome. Benign essential hypertension, severe cerebromicrovascular disease, headache and low grade fever related to intravenous gamma globulin (presumed). Presented with several day history of pure ascending paralysis approximately two weeks after they vacationed in which she had a multitude of mosquito bites. Treated with IV gamma globulin.
VAERS ID: 296434 (history)   Vaccinated: 2007-10-19 Age: 69.0   Onset: 2007-10-20, Days after vaccination: 1 Gender: Female   Submitted: 0000-00-00 Location: California   Entered: 2007-11-12	Life Threatening? No Died? No Permanent Disability? No Recovered? Yes ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Current Illness: None Preexisting Conditions: None PMH: occasional skipped heartbeats w/tachycardia, allergic rhinitis, goiter, asthma & chronic LBP. Allergy to sulfa. Diagnostic Lab Data: CT head neg LABS: CT head showed small vessel ischemic changes. EKG WNL. Troponin slightly elevated 0.39. CXR WNL. MRI & MRA were WNL except for very small vessel ischemic changes. CDC 'Split Type':
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC. 0887U   SC LA
Administered by: Private     Purchased by: Unknown Symptoms: Amnesia, Cerebral ischaemia, Chest X-ray normal, Computerised tomogram normal, Electrocardiogram normal, Global amnesia, Nuclear magnetic resonance imaging, Nuclear magnetic resonance imaging brain abnormal, Troponin increased SMQs:, Myocardial infarction (narrow), Ischaemic cerebrovascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Noninfectious encephalopathy/delirium (broad) Write-up: Pt developed transient global amnesia-memory loss x 12 hrs after the vaccine. fully recovered. 11/27/07 Reviewed hospital medical records which reveal patient experienced acute onset of memory loss & recall for only events that happened 10/20. Admitted 10/20-10/21/2007. Memory returned approx 6-10 hours from initial onset & within 24 hours of admit was completely back to normal. FINAL DX: memory loss, transient, probably secondary to transient global amnesia. 12/21/07 Reviewed pcp medical records which consisted of H&P from hospitalization 10/20/07. No new information.
VAERS ID: 297233 (history)   Vaccinated: 2007-10-09 Age:    Onset: 2007-10-09, Days after vaccination: 0 Gender: Male   Submitted: 2007-11-16, Days after onset: 38 Location: Unknown   Entered: 2007-11-19, Days after submission: 3	Life Threatening? Yes Died? No Permanent Disability? No Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Unknown Current Illness: Preexisting Conditions: Unknown Diagnostic Lab Data: Unknown CDC 'Split Type': WAES0711USA02194
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     UN UN
Administered by: Other     Purchased by: Other Symptoms: Encephalitis herpes, Incorrect dose administered SMQs: Write-up: Information has been received from a pharmacist concerning a male who on approximately 09-OCT-2007 (reported as "about a month ago") was vaccinated with a 0.5 ML dose of Zostavax (Oka/Merck). The pharmacist reported that the patient was hospitalized with herpetic encephalitis. The patient''s herpetic encephalitis persisted. The herpetic encephalitis was considered to be immediately life-threatening. There was no product quality complaint. In follow-up information received 09-NOV-2007, the pharmacist reported that she had limited information. She stated that a nurse came to the pharmacy and mentioned that they had a patient who was very sick and they were trying to figure out what was wrong with him. The nurse mentioned to the pharmacist that she reviewed the patient''s history and the patient had been vaccinated with Zostavax (Oka/Merck) about a month ago. The pharmacist did not have any additional information since she did not review the chart and did not know who the treating physician was. In follow-up information received on 13-NOV-2007, the pharmacist reported that the pharmacy department had no further information. Herpetic encephalitis was considered to be an other important medical event. No further information is available.
VAERS ID: 297249 (history)   Vaccinated: 2007-10-22 Age: 77.0   Onset: 2007-11-07, Days after vaccination: 16 Gender: Female   Submitted: 2007-11-14, Days after onset: 7 Location: Michigan   Entered: 2007-11-19, Days after submission: 5	Life Threatening? No Died? No Permanent Disability? No Recovered? Yes ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: aspirin, calcium with vitamin D, Centrum, hyzaar, ocuvite, gluten, plendil, Prilosec, Zocor, terazostin Current Illness: Preexisting Conditions: hypertension; hypercholesterolemia; allergies to : amoxicillin, beta blockers, and ciproflaxacin 12/6/07-records received-PMH: UTIs, hypertension, osteoarthritis, gastric reflux, hyperlipidema. Diagnostic Lab Data: Spinal CT scan (11/12/07): large pericardial fluid collection; Echocardiogram (11/13/07): moderate to large pericardial present, no tamponade 12/6/07-records received- 2 D echo and CT pulmonary angiogram revealed moderaly large pericardial effusion. CXR normal. Sed rate, erythropoietin and D-dimer elevated. Urinalysis contained WBC.stool leukocyte positive CDC 'Split Type':
Vaccination Manufacturer Lot Dose Route Site FLU: INFLUENZA (SEASONAL) (NO BRAND NAME) UNKNOWN MANUFACTURER     UN UN VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     UN UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Angiogram, Asthenia, Atrial fibrillation, Blood erythropoietin increased, Chest X-ray normal, Computerised tomogram abnormal, Culture stool positive, Diarrhoea, Dyspnoea, Echocardiogram abnormal, Fatigue, Fibrin D dimer increased, Malaise, Pericardial effusion, Pyrexia, Red blood cell sedimentation rate increased, White blood cells urine positive SMQs:, Anaphylactic reaction (broad), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Supraventricular tachyarrhythmias (narrow), Pseudomembranous colitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Chronic kidney disease (broad) Write-up: Patient received influenza and Zostavax vaccines on 10/22. the next day she began to feel tired, weak, and generally not well. Over time she noticed shortness of breath with mild exertion. On admission she denied any fever, nausea, vomiting, diarrhea, abdominal pain, chest pain, headache, or neck stiffness. During hospitalization she did present with low grade fever along with previously described symptoms. A large pericardial effusion was detected upon further testing.12/06/07-records received for DOS 11/7-11/14/07- Developed diarrhea and stool leukocyte positive.Weak, low grade fever, malaise, dyspnea, atrial fibrillation. Impression: probably autoimmune phenomenon possible related to recent immunizations, Pericarditis. Per 60 day follow up: Atrial fibrillation developed during hospitalization related to acute pericarditis. Pt was discharged home 11/14/2007. Patient is still alive, had lab work 1/21/2008.
VAERS ID: 297418 (history)   Vaccinated: 0000-00-00 Age: 70.0   Onset: 0000-00-00 Gender: Male   Submitted: 2007-11-19 Location: Massachusetts   Entered: 2007-11-20, Days after submission: 1	Life Threatening? No Died? No Permanent Disability? No Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Unknown Current Illness: Preexisting Conditions: Unknown Diagnostic Lab Data: Unknown CDC 'Split Type': WAES0711USA02963
Vaccination Manufacturer Lot Dose Route Site FLU: INFLUENZA (SEASONAL) (NO BRAND NAME) UNKNOWN MANUFACTURER     UN UN VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     UN UN
Administered by: Unknown     Purchased by: Unknown Symptoms: Dysuria, Syncope SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad) Write-up: Information has been received from a physician concerning a male approximately in his "early 70''s" who at 08:00 (date unspecified) was vaccinated with a single dose of Zostavax (Oka/Merck). Concomitant vaccination administered on that same day at 08:00 included a dose of influenza virus vaccine (unspecified). Subsequently the patient experienced trouble urinating from about 12:00 until 04:00 and then fainted. The patient went to the emergency room and was subsequently admitted to the hospital for an overnight stay. The patient was able to urinate around 04:00 and was noted to be recovering. Medical treatment in the hospital was not specified. There was no product quality complaint. Additional information has been requested.
VAERS ID: 297560 (history)   Vaccinated: 2007-10-04 Age: 68.0   Onset: 2007-10-10, Days after vaccination: 6 Gender: Female   Submitted: 0000-00-00 Location: Indiana   Entered: 2007-11-23	Life Threatening? No Died? No Permanent Disability? No Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Current Illness: Preexisting Conditions: PMH: HTN. Skin cancer. Diagnostic Lab Data: LABS: brain MRI showed chronic small vessel ischemic changes. CBC revealed neutros 73.4% (H), lymphs 19.6% (L) CDC 'Split Type':
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC. 0886U 0 IM UN
Administered by: Private     Purchased by: Private Symptoms: Abasia, Balance disorder, Blood pressure decreased, Blood test, Cerebral ischaemia, Computerised tomogram, Deafness neurosensory, Disorientation, Dizziness, Erythema, Hyperhidrosis, Lymphocyte count decreased, Nausea, Neutrophil percentage increased, Nuclear magnetic resonance imaging, Nuclear magnetic resonance imaging brain abnormal, Pain, Photophobia, Photosensitivity reaction, Pruritus, Rash, Tinnitus, Vertigo, Vestibular neuronitis, Vomiting SMQs:, Anaphylactic reaction (narrow), Acute pancreatitis (broad), Haematopoietic leukopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (narrow), Ischaemic cerebrovascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Dystonia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Corneal disorders (broad), Retinal disorders (broad), Hearing impairment (narrow), Vestibular disorders (narrow), Hypersensitivity (narrow) Write-up: Received shot 10-4-07, 10-10-07 became dizzy nauseated, sweating, blood pressure dropped, ringing in the ears and sensitive to lights, 10-12-07 vomiting/ unable to walk, went to hospital. Cat Scan, MRI, IV''s, bloodtest. Went to ear specialist and had hearing checked 10-19-07 broke out in red, lumpy, painful rash that was itchy later. It lasted 2 weeks. 11-16-07 I''m still dizzy but slowly getting better. On October 4, 2007 I received the Zostavax vaccine at doctor''s office 10-10-07 I was shopping and I began to get real warm, sweat, and was very dizzy and nauseated. It lasted 6 hours. 10-11-07 the nausea started later in the day and lasted around 5 hours. I had a terrible ringing in my ears and lights were really hard on my eyes. My blood pressure kept dropping. The lights made more disoriented. 10-12-07 with-in 1/2 hour after getting up in the morning I was so dizzy and vomiting I could not function at all. I was taken to the emergency room. They took blood test, Cat Scan and put in IV''s. The doctor ordered an MRI and had me admitted to the hospital for over night. I left the hospital on 10-13-07 even though I was still having problems. I went for a check up with the doctor on 10-15-07 and she sent me to see an ear specialist for inner ear problems. He recommended I go for therapy. Before my appointment on 10-23-07 I had more side effects. On 10-19-07 I broke out in a red, itchy, lumpy rash. It feels like a bad sun burn. It extends from ears all the way to my stomach. It is the worst on my neck and chest. I''m slowly regaining my balance and being in well lit areas isn''t as bad on my eyes now. I was told I was probably contagious so I''m home bound until this clears up. This has been a very expensive side effect with all the testing, doctors, hospital and ambulance. 12/4/07 Reviewed ENT medical records which reveal patient seen 10/16/07 for continued vertigo which originally had been spinning & now was severe imbalance along w/continued tinnitus, photophobia & nausea/vomiting minimally controlled by meds. Audiogr
VAERS ID: 297566 (history)   Vaccinated: 2007-11-12 Age: 64.0   Onset: 2007-11-14, Days after vaccination: 2 Gender: Female   Submitted: 2007-11-20, Days after onset: 6 Location: Pennsylvania   Entered: 2007-11-23, Days after submission: 3	Life Threatening? No Died? No Permanent Disability? No Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Current Illness: Preexisting Conditions: Allergies - eggs; HTN; High cholesterol, Factor V Leidin; Osteoporosis; Anxiety PMH: plastic surgery 6 wks prior to admit. Factor 11 deficiency requiring FFP. HTN. Hyperlipidemia. Diagnostic Lab Data: LABS: EKG sinus tachycardia. Troponin 0.19-0.21 was not considered diagnostic of myocardial injury. CBC, chemistry, LFT & TSH WNL. CXR WNL. Echocardiogram WNL. Stress test was WNL. CDC 'Split Type':
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC. 1080U 0 UN LA
Administered by: Private     Purchased by: Private Symptoms: Asthenia, Blood thyroid stimulating hormone, Cardiac stress test normal, Chest X-ray normal, Dizziness, Dyspnoea exertional, Echocardiogram normal, Electrocardiogram abnormal, Fatigue, Full blood count normal, Injection site erythema, Injection site swelling, Injection site warmth, Laboratory test normal, Liver function test normal, Local reaction, Nausea, Palpitations, Sinus tachycardia, Tremor, Troponin increased SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Supraventricular tachyarrhythmias (broad), Parkinson-like events (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Vestibular disorders (broad) Write-up: 11/14/07 (-) Fever, (L) arm-site of injection-Red/warm/swollen- Rx Clobetasol Cream BID 11/15/07 TC prompt-states she feels weak/shakey + having heart palpitations-went to ER-Hospitalized overnight. 12/28/07 Reviewed hospital medical records which reveal patient experienced symptomatic palpitations with lightheadedness, fatigue, DOE & nausea since 11/12/07. Also had a local reaction to vax. Admitted 11/15-11/16/2007. Remained stable & d/c to home w/f/u troponin to be obtained as outpatient. FINAL DX: symptomatic sinus tachycardia.
VAERS ID: 297887 (history)   Vaccinated: 2007-08-14 Age: 90.0   Onset: 2007-08-20, Days after vaccination: 6 Gender: Female   Submitted: 2007-11-26, Days after onset: 98 Location: Colorado   Entered: 2007-11-27, Days after submission: 1	Life Threatening? No Died? No Permanent Disability? Yes Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Unknown Current Illness: Pain Preexisting Conditions: Diagnostic Lab Data: Unknown CDC 'Split Type': WAES0711USA03655
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC. 0744U   UN UN
Administered by: Other     Purchased by: Other Symptoms: Herpes zoster SMQs: Write-up: Information has been received from a physician concerning a 90 year old female who on 14-AUG-2007 was vaccinated with a dose of Zostavax (Oka/Merck) (lot number: 658082/0744U). On 20-AUG-2007 the patient developed shingles in the lower quadrant of her body. On 23-AUG-2007 the patient was hospitalized, but it was not specified how long the hospital stay was. The physician also reported that before receiving the vaccination, the patient had complained of non-descript pain in her lower quadrant of her body. No further adverse event information. There was no product quality complaint. The event was considered to be disabling by the reporter. Additional information has been requested.